Close
FINDING CURES TOGETHER<sup>SM</sup>
  • Home
  • Award-Lectureship Detail

AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research

Nomination Status Open
Nomination Deadline 09/05/2018
Generously Supported By Bristol-Myers Squibb


Description

Nominate a Candidate

Nomination Instructions 

This award was established in 1996 to recognize outstanding achievements in clinical cancer research. It is named for the late Dr. Joseph H. Burchenal, honorary member and past president of the AACR, and a major figure in clinical cancer research and chemotherapy.

The winner of the 24th AACR-Joseph H. Burchenal Memorial Award for Outstanding Achievement in Clinical Cancer Research will give an award lecture during the AACR Annual Meeting 2019, in Atlanta, Georgia, USA (March 30-April 3, 2019), receive an honorarium of $10,000, and will be given support for the winner and a guest to attend the Annual Meeting.

Eligibility Criteria

  • Candidacy is open to all cancer researchers who are affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science anywhere in the world. Such institutions include those in academia, industry or government.

  • The award will be presented to an individual investigator.

  • Institutions or organizations are not eligible for the award.

Contact Information

awards@aacr.org

Nomination Procedure

Nominations may be made by any scientist, whether an AACR member or nonmember, who is now or has been affiliated with any institution involved in cancer research, cancer medicine or cancer-related biomedical science. Candidates may not nominate themselves.

Nominations must be submitted online at myaacr.aacr.org by 4 p.m. U.S. ET on Wednesday, September 5, 2018. Paper nominations cannot be accepted.

Nomination materials to be submitted are:

1) Nomination Letter Must:

  • be addressed to the Selection Committee; be written in English; and not exceed 1,000 words;

  • specify the AACR Award for which the candidate is being nominated;

  • contain a concise description of the candidate's outstanding achievements in clinical cancer research; publications supporting these contributions must be directly referenced within the letter;

  • contain a concise description of the impact of these contributions on the field; and

  • be signed with a handwritten signature by the nominator(s).

2) Candidate's CV. The candidate's curriculum vitae in English, including a complete list of the candidate's publications.

3) Summary Statement. A statement, no more than 50 words, summarizing the candidate's research accomplishments for which he or she is being nominated.

See the Program Guidelines and Nomination Instructions for complete details.

Adobe Reader 

Selection Process

​Candidates will be considered by a Selection Committee of international cancer leaders appointed by the president of the AACR. After careful deliberations by the committee, its recommendations will be forwarded to the Executive Committee of the AACR for final consideration and decision. Selection of the award winner will be made on the basis of the candidate's achievements in clinical cancer research. No regard will be given to age, race, gender, nationality, geographic location or religious or political views.